Gupta, V., Kosiorek, H., Mead, A., Klisovic, R., Galvin, J., Berenzon, D., . . . Hoffman, R. (2018). Ruxolitinib therapy followed by reduced-intensity conditioning for hematopoietic cell transplantation for myelofibrosis: Myeloproliferative Disorders Research Consortium 114 study. Elsevier.
Cita Chicago (17th ed.)Gupta, V., et al. Ruxolitinib Therapy Followed by Reduced-intensity Conditioning for Hematopoietic Cell Transplantation for Myelofibrosis: Myeloproliferative Disorders Research Consortium 114 Study. Elsevier, 2018.
Cita MLA (9th ed.)Gupta, V., et al. Ruxolitinib Therapy Followed by Reduced-intensity Conditioning for Hematopoietic Cell Transplantation for Myelofibrosis: Myeloproliferative Disorders Research Consortium 114 Study. Elsevier, 2018.